EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes

Amy B Karger, Ilya M Nasrallah, Barbara H Braffett iD, José A Luchsinger iD, Christopher M Ryan, Ionut Bebu iD, Valerie Arends, Mohamad Habes, Rose A Gubitosi-Klug iD, Naomi Chaytor iD, Geert J Biessels iD, Alan M Jacobson und 1 weitere

Diabetes Care · 01.09.2024 · 47 (9) · 1530-1538

DOI: 10.2337/dc24-0229 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Diabetes Care, online erschienen am 11.06.2024. Verfasst von Amy B Karger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN. Hauptthemen laut MEDLINE: Biomarkers, Brain Injuries, Magnetic Resonance Imaging, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To evaluate associations between plasma biomarkers of brain injury and MRI and cognitive measures in participants with type 1 diabetes (T1D) from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. RESEARCH DESIGN AND METHODS Plasma amyloid-β-40, amyloid-β-42, neurofilament light chain (NfL), phosphorylated Tau-181 (pTau-181), and glial fibrillary acidic protein (GFAP) were measured in 373 adults who participated in the DCCT/EDIC study. MRI assessments included total brain and white matter hyperintensity volumes, white matter mean fractional anisotropy, and indices of Alzheimer disease (AD)–like atrophy and predicted brain age. Cognitive measures included memory and psychomotor and mental efficiency tests and assessments of cognitive impairment. RESULTS Participants were 60 (range 44–74) years old with 38 (30–51) years’ T1D duration. Higher NfL was associated with an increase in predicted brain age (0.51 years per 20% increase in NfL; P < 0.001) and a 19.5% increase in the odds of impaired cognition (P < 0.01). Higher NfL and pTau-181 were associated with lower psychomotor and mental efficiency (P < 0.001) but not poorer memory. Amyloid-β measures were not associated with study measures. A 1% increase in mean HbA1c was associated with a 14.6% higher NfL and 12.8% higher pTau-181 (P < 0.0001). CONCLUSIONS In this aging T1D cohort, biomarkers of brain injury did not demonstrate an AD-like profile. NfL emerged as a biomarker of interest in T1D because of its association with higher HbA1c, accelerated brain aging on MRI, and cognitive dysfunction. Our study suggests that early neurodegeneration in adults with T1D is likely due to non-AD/nonamyloid mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersBrain InjuriesMagnetic Resonance ImagingDiabetes Mellitus, Type 1CognitionHumansNeurofilament Proteinstau ProteinsGlial Fibrillary Acidic ProteinMaleFemaleAdultMiddle AgedAgedCohort Studies

Substanzen

BiomarkersNeurofilament Proteinstau ProteinsGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.
  • Department of Radiology, University of Pennsylvania, Philadelphia, PA.
  • The Biostatistics Center, George Washington University, Rockville, MD.
  • Columbia University Irving Medical Center, New York, NY.
  • Pitt Public Health, University of Pittsburgh, Pittsburgh, PA.
  • Neuroimage Analytics Laboratory and Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center San Antonio, San Antonino, TX.

ORCID-Profile: Barbara H Braffett, José A Luchsinger, Ionut Bebu, Rose A Gubitosi-Klug, Naomi Chaytor, Geert J Biessels

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS
  • Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Karger, A. B., Nasrallah, I. M., Braffett, B. H., Luchsinger, J. A., Ryan, C. M., Bebu, I., Arends, V., Habes, M., Gubitosi-Klug, R. A., Chaytor, N., Biessels, G. J., Jacobson, A. M., & DCCT/EDIC Research Group (2024). Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes. Diabetes Care, 47(9), 1530-1538. https://doi.org/10.2337/dc24-0229

Vancouver

Karger AB, Nasrallah IM, Braffett BH, Luchsinger JA, Ryan CM, Bebu I, et al. Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes. Diabetes Care. 2024;47(9):1530-1538. doi:10.2337/dc24-0229

BibTeX
@article{Karger2024,
  author = {Karger, Amy B and Nasrallah, Ilya M and Braffett, Barbara H and Luchsinger, José A and Ryan, Christopher M and Bebu, Ionut and Arends, Valerie and Habes, Mohamad and Gubitosi-Klug, Rose A and Chaytor, Naomi and Biessels, Geert J and Jacobson, Alan M and DCCT/EDIC Research Group, DCCT/EDIC Research Group},
  title = {Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes},
  journal = {Diabetes Care},
  year = {2024},
  volume = {47},
  number = {9},
  pages = {1530--1538},
  doi = {10.2337/dc24-0229}
}
Kostenlos starten →